To support ITMIG, please DONATE
  1. Home
  2. ITMIG Events
  3. ITMIG Webinars

ITMIG Webinars

WEBINARS 2025

WATCH THE RECORDINGS!

Recent Updates from Clinical Trials and Emerging Treatment Options for TETs

Webinar presented on May 6, 2025

“Emerging Radiation Therapy Treatment Options for Thymic Malignancies”

Dr. Charles B. Simone, II – Radiation Oncologist, New York Proton Center/Memorial Sloan Kettering Cancer Center, USA

“Targeting Thymic Epithelial Tumors”

Dr. Jennifer A. Marks – Medical Oncologist, Dana-Farber Cancer Institute, USA

“Recent Updates from Clinical Trials and Emerging Treatment Options for TETs”

Dr. Clémence Basse – Medical Oncologist, Institut Curie, France

“Subxyphoid thymectomy  approach for Thymic Epithelial Tumors resection”

Thoracic Surgeon, Dr. Geoffrey Brioude, Hôpitaux de Marseille, Marseille, France

“The grey zone for PORT indication in completely resected IIb/III thymoma– RADIORYTHMIC trial”

Thoracic-Oncologist, Pr. Nicolas Girard, Institut Curie, Paris, France

“French harmonization for PORT – Delphi process”

Radiation Oncologist, Dr. Angela Botticella, Institut Gustave Roussy, Paris, France

“Difficulties for TET classification, and novel 9th TNM (second review in the RYTHMIC network)”

Pathologist, Pr. Thierry Molina, Hôpital Necker, Paris, France

2025 Advancements in Thymic Epithelial Tumor Care

Webinar presented on May 13, 2025

Treatment of Thymic Epithelial Tumors in the Era of the 9th Ed. TNM:  The Current State of Art

Webinar presented on May 20, 2025

“Surgical Treatment of Thymic Epithelial Tumors”

Prof. Dirk Van Raemdonck, Thoracic Surgeon from University Hospitals Leuven, Belgium

„Radiation Treatment of Thymic Epithelial Tumors in the Era of the 9th Ed. TNM”

Dr. Annamarie Shepherd, Radiation Oncologist from the University of Washington, USA

“Oncological Treatment of Thymic Epithelial Tumors”

Dr. Rohan Maniar, Medical Oncologist from Indiana University, USA

MORE RECORDINGS COMING SOON

WEBINARS 2024

WATCH THE RECORDINGS!
Clinical trials for thymic tumors

Moderator: Dr. Chul Kim, Medical Oncologist

Speakers:

  • Dr. Claudia Proto, Medical Oncologist
  • Dr. Jennifer Marks, Medical Oncologist
  • Dr. Clemence Basse, Medical Oncologist

Webinar for Patients

Questions I’d like to ask my doctor

 

Organizer: ITMIG Communication Committee

Patients’ questions submitted before the webinar were answered by doctors:

  • Conrad Falkson, Radiation Oncologist, Queen’s University and CCSEO @ KHSC Kingston, Canada
  • Dirk Van Raemdonck, Thoracic surgeon, University Hospitals Leuven, Belgium
  • Arun Rajan, Medical Oncologist, National Cancer Institute, National Institutes of Health, Bethesda, United States
  • Edith Marom, Diagnostic Radiologist, The Chaim Sheba Medical Center, Ramat Gan, Israel

Moderator: Malgorzata Szolkowska, Pathologist, The Institute of Tuberculosis and Lung Diseases, Warsaw, Poland

Webinars 2023

Webinars organized in May 2023 on the Thymic Malignancy Awareness Month

Free access to recordings - click on the image of chosen webinar

Webinars for Physicians

Clinical Trials for Thymic Epithelial Tumors

Scientific Organizer: ITMIG Communication Committee

Moderator: Chul Kim, Georgetown University, Washington, DC, USA 

PROGRAM:

  1. Meredith McAdams, National Cancer Institute, National Institutes of Health, Bethesda, USA:
    – (NCT05104736) PT-112 in Subjects with Thymoma and Thymic Carcinoma
    – (NCT04417660) Bintrafusp Alfa (M7824) in Subjects with Thymoma and Thymic Carcinoma
  2. Dwight Owen, Ohio State University – James Comprehensive Cancer Center, Columbus, OH, USA: (NCT03463460) Pembrolizumab and Sunitinib in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
  3. Chris Nabel, Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA: (NCT04262466) Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
  4. Annemarie Shepherd, Memorial Sloan Kettering Cancer Center, New York, NY, USA: (NCT05354570) A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest
  5. Q&A
Joint STR/ITMIG Thymic Imaging Webinar

 

Scientific Organizers: STR and ITMIG

Moderator: Cristina Fuss, MD, PhD, Professor of Radiology, Department of Diagnostic Radiology, Oregon Health & Science University, Portland, OR, USA

PROGRAM:

  1. PET of thymus, Chad Strange, MD, Associate Professor of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
  2. Thymic disorder mimics: Mediastinal masses, Sanjeev Bhalla, MD, Professor of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA
  3. Thymic neoplasms CT/MRI: When, how, why? Constantine Raptis, MD, Professor of Diagnostic Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA
  4. MRI: Your Thymus’ best friend, Jeanne Ackman, MD, Assistant Professor, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
  5. Q&A
Webinar in Polish: Grasiczaki i raki grasicy – aktualności w zakresie diagnostyki i leczenia. Prezentacja przypadków i dyskusja wielodyscyplinarna

 

Organizator naukowy: ITMIG Communication Committee

W oparciu o przypadki kliniczno-radiologiczno-histopatologiczne omówiono m.in.:

  • Aktualne zasady oceny stopnia zaawansowania (staging) grasiczaków i raków grasicy według TNM
  • Wskazania i przeciwskazania do chirurgii małoinwazyjnej w guzach śródpiersia
  • Kiedy wykonywać biopsję guza śródpiersia?
  • Miejsce leczenia neoadjuwantowego
  • Radioterapia adjuwantowa – wskazania do leczenia według różnych towarzystw naukowych
  • Kontrola chorych po resekcji guza śródpiersia – jak często, jak długo i jaką metodą?

Moderacja:

Dr hab. n. med. prof. IGiChP Małgorzata Szołkowska, Zakład Patomorfologii, Instytut Gruźlicy i Chorób Płuc, Warszawa

Dr n. med. Magdalena Knetki-Wróblewska, Klinika Nowotworów Płuca i Klatki Piersiowej, Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy, Warszawa

Prelegenci:

  1. Dr n. med. Katarzyna Błasińska, Zakład Radiologii, Instytut Gruźlicy i Chorób Płuc, Warszawa
  2. Dr n. med. Magdalena Knetki-Wróblewska, Klinika Nowotworów Płuca i Klatki Piersiowej, Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy, Warszawa
  3. Dr hab. n. med. Tomasz Marjański, Katedra i Klinika Chirurgii Klatki Piersiowej Gdański Uniwersytet Medyczny, Gdańsk
  4. Dr hab. n. med. prof. IGiChP Małgorzata Szołkowska, Zakład Patomorfologii, Instytut Gruźlicy i Chorób Płuc, Warszawa
  5. Dr n. med. Anna Wrona, Katedra i Klinika Onkologii i Radioterapii Gdański Uniwersytet Medyczny, Gdańsk

Webinars 2022

Webinars organized in May 2022 on the Thymic Malignancy Awareness Month

Webinars for Patients

Organizer: ITMIG Communication Committee

Patients’ questions were answered by doctors:

  • Joshua Sonett, thoracic surgeon, NewYork-Presbyterian/Columbia University Medical Center, New York, USA 
  • Arun Rajan, medical oncologist, National Cancer Institute, National Institutes of Health (NCI/NIH), Bethesda, USA
  • Andreas Rimner, radiation oncologist, Memorial Sloan Kettering Cancer Center, New York, USA
  • Edith Marom, diagnostic radiologist, The Chaim Sheba Medical Center, Ramat Gan, Israel

Moderator: Malgorzata Szolkowska, pathologist, The Institute of Tuberculosis and Lung Diseases, Warsaw, Poland

Organizer: ITMIG Communication Committee

Presenters: 

  • Paul Van Schil, thoracic surgeon, from the Antwerp University Hospital and Antwerp University (Antwerp, Belgium)
  • Frank Detterbeck, thoracic surgeon, from the Yale University School of Medicine (New Haven, CT, USA)
  • Q&A

Webinars for Physicians

Scientific Organizer: Giuseppe Cardillo, Chief of Thoracic Surgery, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy

Technical Organizer: ITMIG Communication Committee

Program: 

Moderator: Giuseppe Cardillo (Italy)

  • Introduction, Giuseppe Cardillo (Italy)
  • The surgeon’s needs, Enrico Ruffini (Italy)
  • The pathological boundaries of the TNM classification, Anja Roden (USA)
  • The radiologist’s view, Edith Marom (Israel)
  • The oncologist’ s perspective, Nicolas Girard (France)
  • Towards the 9th edition, Thierry Molina (France)
  • Q&A

Scientific Organizer: Mirella Marino, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Technical Organizer: ITMIG Communication Committee

Program: 

Moderator: Mirella Marino, IRCCS Regina Elena National Cancer Institute, Rome, Italy

  • Rebuilding the human thymus complexity, Paola Bonfanti, The Francis Crick Institute and UCL, London, UK
  • An overview of laboratory tools in thymic epithelial tumors research, Mirella Marino, IRCCS Regina Elena National Cancer Institute, Rome, Italy
  • Molecular pathology meets oncology, Alexander Marx, Universitätsklinikum Mannheim GmbH, Mannheim, Germany
  • Mediastinal lymphomas vs. thymomas: a source of diagnostic pitfalls, Lucia Anemona, University of Rome, Tor Vergata, Rome, Italy
  • Good’s syndrome: new insights, Giovannella Palmieri, CRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy
  • Q&A

Webinar Committee

Main organizers: 

Malgorzata Szolkowska – pathologist, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Pam Bruce, Executive Director of ITMIG, New York, USA

Edith Marom – diagnostic radiologist, The Chaim Sheba Medical Center, Ramat Gan, Israel

 

Our webinars could not appear without help of the following experts:

(in alphabetical order)

Katarzyna Blasinska – diagnostic radiologist, Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Frank Detterbeck – thoracic surgeon, Yale University School of Medicine, New Haven, CT, USA

Conrad Falkson – radiation oncologist, Queen’s University and Kingston Health Sciences Center, Kingston, Ontario, Canada

Nicolas Girard – medical oncologist, Institut Curie, Paris, France

Maria Isabel Leite – neurologist, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK

Arun Rajan – medical oncologist, National Cancer Institute, National Institutes of Health (NCI/NIH), Bethesda, USA

Andreas Rimner – radiation oncologist, Memorial Sloan Kettering Cancer Center, New York, USA

Anja Roden – pathologist, Mayo Clinic Rochester, Rochester, MN, USA

Paul van Schil – thoracic surgeon, Antwerp University Hospital, Edegem (Antwerp), Belgium

Webinars 2021

Webinars for Patients: 

Series: EXPERTS EXPLAIN

Part 1: Imaging of thymic tumors. How should I understand my diagnosis?

Part 2: Surgical treatment of mediastinal tumours: from maximally invasive to minimally invasive techniques

Part 3: Radiotherapy of thymic epithelial tumors

Part 4: Oncological Treatment for Advanced Thymic Tumors – Definitions and Strategies

Part 5: Clinical Trials for Thymic Epithelial Tumors

Webinars 2020

Webinar for Patients: 

The questions I would like to ask my doctor

Webinars for Physicians: 

Series: Diagnosis and Treatment of Thymic Epithelial Tumors

Webinar Committee

Main organizers: 

Malgorzata Szolkowska – pathologist, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Pam Bruce, Executive Director of ITMIG, New York, USA

Edith Marom – diagnostic radiologist, The Chaim Sheba Medical Center, Ramat Gan, Israel

 

Our webinars could not appear without help of the following experts:

(in alphabetical order)

Katarzyna Blasinska – diagnostic radiologist, Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Frank Detterbeck – thoracic surgeon, Yale University School of Medicine, New Haven, CT, USA

Conrad Falkson – radiation oncologist, Queen’s University and Kingston Health Sciences Center, Kingston, Ontario, Canada

Nicolas Girard – medical oncologist, Institut Curie, Paris, France

Maria Isabel Leite – neurologist, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK

Arun Rajan – medical oncologist, National Cancer Institute, National Institutes of Health (NCI/NIH), Bethesda, USA

Andreas Rimner – radiation oncologist, Memorial Sloan Kettering Cancer Center, New York, USA

Anja Roden – pathologist, Mayo Clinic Rochester, Rochester, MN, USA

Paul van Schil – thoracic surgeon, Antwerp University Hospital, Edegem (Antwerp), Belgium

Last update May 2022

ITMIG

Privacy Policy